{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Evelo Biosciences, Inc.
Is Evelo Biosciences, Inc. technically bullish or bearish?
As of May 7, 2025, the market trend is mildly bearish, driven by daily moving averages and a bearish weekly RSI, despite mixed signals from the monthly bullish RSI and mildly bullish MACD.
Who are in the management team of Evelo Biosciences, Inc.?
As of March 2022, Evelo Biosciences, Inc. is led by Chairman Mr. David Epstein and CEO Dr. Balkrishan Gill, with a Board of Directors that includes independent members such as Mr. Juan Andres and Prof. Lord Ara Darzi.
How big is Evelo Biosciences, Inc.?
As of Jun 18, Evelo Biosciences, Inc. has a market capitalization of 0.01, classifying it as a Micro Cap company, with net sales of 0.00 million and a net profit of -82.34 million over the last four quarters. Shareholder's funds are reported at -4.99 million, and total assets amount to 64.44 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
